Immatics Ownership

IMTX Stock

USD 9.78 0.00 0.00%

Some institutional investors establish a significant position in stocks such as Immatics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Immatics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Check out Risk vs Return Analysis to better understand how to build diversified portfolios.

Immatics Price to Earnings Ratio are fairly stable at the moment as compared to the past year. Immatics reported Price to Earnings Ratio of 14.62 in 2022. Price to Sales Ratio is likely to rise to 3.19 in 2023, whereas Asset Turnover is likely to drop 0.39 in 2023.

Immatics NV has a total of seventy-six million six hundred seventy-one thousand five hundred four outstanding shares. Immatics secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investors. class="underlinedLink" href="/invest/ratio/IMTX/Shares-Owned-by-Institutions">institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how much assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Market Capitalization Enterprise Value

Immatics Stock Ownership Analysis

About 26.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.19. Immatics NV had not issued any dividends in recent years. Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 388 people. To learn more about Immatics NV call Harpreet Singh at 49 7071 5397 0 or check out https://www.immatics.com.

Besides selling stocks to institutional investors. Immatics also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Immatics' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Immatics' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Immatics Quarterly Share Based Compensation

6.1 Million

About 26.0% of Immatics NV are currently held by insiders. Unlike Immatics' institutional investors. corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Immatics' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%.

Immatics SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Immatics prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Immatics investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Immatics NV specific information freely available to individual and institutional investors.to make a timely investment decision.

	26th of May 2023 Other Events	View
	14th of February 2023 Unclassified Corporate Event	View

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immatics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immatics' short interest history, or implied volatility extrapolated from Immatics options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immatics NV using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Immatics Stock analysis

When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.

	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Global Correlations Find global opportunities by holding instruments from different markets
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Technical Analysis Check basic technical indicators and analysis based on most latest market data

Is Immatics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.19)

Revenue Per Share

1.128

Quarterly Revenue Growth

(0.91)

Return On Assets

(0.12)

Return On Equity

(0.43)

The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immatics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Check out Risk vs Return Analysis to better understand how to build diversified portfolios.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

Immatics Ownership

Immatics Stock Ownership Analysis

Immatics Quarterly Share Based Compensation

6.1 Million

Immatics SEC Filings

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Immatics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY